Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Warts 2 Melanoma 2 Hyperthermia 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Seizures 1 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphoma, T-Cell 1 Lennox Gastaut Syndrome 1 Hemorrhage 1 Hematologic Neoplasms 1 Epilepsies, Myoclonic 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Doxorubicin 15 pembrolizumab 12 Cyclophosphamide 9 Surgical Procedures, Operative 8 Gemcitabine 8 Blood Specimen Collection 8 Ifosfamide 7 Surveys and Questionnaires 6 Nivolumab 6 Trabectedin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Drug Therapy 5 fludarabine 4 Temozolomide 4 Specimen Handling 4 Radiation Dose Hypofractionation 4 Biopsy 4 selinexor 3 pazopanib 3 liposomal doxorubicin 3 cabozantinib 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Docetaxel 3 Dacarbazine 3 trastuzumab deruxtecan 2 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Solutions × Clear all

NCT03886311 2025-02-24

TNT

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡